In a xenograft model, intraperitoneal (i.p.)injection of ANGII significantly increases the tumorigenicity and metastasis of ovarian cancer cells, whereas an AGTR1 antagonist, losartan, suppresses this effect. The gene discussed is AGT; the disease is ovarian carcinoma.